dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

Patient Education

  • There is no clear evidence of specific association between lifestyle factors and dyspepsia, but some individuals may be helped by these measures
  • To reduce anxiety, in cases where there are no indications of organic disease, reassurance is an important part of initial therapy
  • Provide patients with access to educational materials to support the care they receive

Lifestyle Modification

  • Advise patients to avoid known precipitants that they associate with dyspeptic symptoms eg alcohol, coffee, chocolate and fatty foods
    • Alcohol, coffee, and chocolate have pharmacological effects that may reduce the tone of the lower esophageal sphincter (LES)
    • Fatty foods delay gastric emptying time which may also predispose to GERD
  • Encourage patient to stop smoking
    • Smoking has pharmacological effects that may reduce the tone of the LES
  • Weight reduction for overweight and obese patients
    • Obesity may disrupt the LES due to mechanical pressure on the diaphragm
  • May suggest having a main meal well before going to bed (preferably 3 hours before)
  • Some patients may benefit from raising the head when sleeping
    • Lying flat may increase reflux episodes since gravity does not prevent acid regurgitation

Other Considerations

  • If there is concurrent use of NSAIDs, evaluate for risk of GI complications and consider alternative strategies if risk is a concern
    • See PUD Disease Management Chart for details
  • Patients with refractory functional dyspepsia are those who are unresponsive to either initial acid suppression therapy or H pylori eradication; have a high rate of accompanying depression and psychiatric illness
    • May consider psychological therapies, eg cognitive behavioral therapy (CBT) and psychotherapy, or antidepressants to reduce dyspeptic symptoms especially in non-ulcer dyspepsia
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

28 Apr 2017
Silymarin does not appear to be significantly better than placebo in reducing disease activity by 30 percent or more in patients with nonalcoholic steatohepatitis (NASH), according to the results of a trial.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.